Back to Search
Start Over
Corrigendum to 'PTPN3 is a potential target for a new cancer immunotherapy that has a dual effect of T cell activation and direct cancer inhibition in lung neuroendocrine tumor' [Volume 14, Issue 9, September 2021, 101152]
- Source :
- Translational Oncology, Vol 17, Iss , Pp 101344- (2022)
- Publication Year :
- 2022
- Publisher :
- Elsevier, 2022.
- Subjects :
- Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Subjects
Details
- Language :
- English
- ISSN :
- 19365233
- Volume :
- 17
- Issue :
- 101344-
- Database :
- Directory of Open Access Journals
- Journal :
- Translational Oncology
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.8358138816e4f5e92ea2ab235375183
- Document Type :
- article
- Full Text :
- https://doi.org/10.1016/j.tranon.2022.101344